Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 9478-9479 [2016-03928]

Download as PDF 9478 Federal Register / Vol. 81, No. 37 / Thursday, February 25, 2016 / Notices ICD–10–PCS Topics Removal of Thrombus and Emboli Insertion of Endobronchial Coils Hematopoietic Cell Transplant Donor Fluorescence Vascular Angiography (FVA) (FVA) Rapid Deployment Aortic Valve Replacement Replacement Branch Endograft Repair of Common Iliac Aneurysm Total Anomalous Pulmonary Venous Return Administration of Andexanet Alfa Injection for I.V. Infusion Administration of VISTOGARD (uridine triacetate) Mechanical Embolectomy with Stent Retriever Retrieve Intracranial Aneurysm Procedure Using Flow Diverter Stent Spinal Bracing and Distraction System Interbody Spinal Fusion with NanoTextured Surface Therapeutic Artificial Rupture of Membranes Application of Biologic Wound Matrix (MircoDERM) Oxidized Zirconium on Polyethylene Bearing Surfaces GEM Structure and Update Requests Addenda and Key Updates ICD–10–CM Diagnosis Topics mstockstill on DSK4VPTVN1PROD with NOTICES Antenatal Screening Clostridium difficile Congential Sacral Dimple Exercise Counseling Hepatic Encephalopathy Lacunar Infarction Pediatric Cryptorchidism Post-operative Seroma Soft Tissue Sarcoma Spinal Stenosis Temporomandibular Joint Disorders Zika Virus Infection ICD–10–CM Addendum Agenda items are subject to change as priorities dictate. Note: CMS and NCHS no longer provide paper copies of handouts for the meeting. Electronic copies of all meeting materials will be posted on the CMS and NCHS Web sites prior to the meeting at http:// www.cms.hhs.gov/ICD9Provider DiagnosticCodes/03_ meetings.asp#TopOfPage and http:// www.cdc.gov/nchs/icd/icd9cm_ maintenance.htm Contact Persons for Additional Information: Donna Pickett, Medical Systems Administrator, Classifications and Public Health Data Standards Staff, NCHS, 3311 Toledo Road, Hyattsville, Maryland 20782, email dfp4@cdc.gov, telephone 301–458– 4434 (diagnosis); Mady Hue, Health Insurance Specialist, Division of Acute Care, CMS, 7500 Security Boulevard, Baltimore, Maryland 21244, email marilu.hue@ cms.hhs.gov, telephone 410–786–4510 (procedures). VerDate Sep<11>2014 18:07 Feb 24, 2016 Jkt 238001 The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2016–03930 Filed 2–24–16; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), and pursuant to the requirements of 42 CFR 83.15(a), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Times and Dates: 9:00 a.m.–5:00 p.m., Eastern Time, March 23, 2015; 8:15 a.m.–12:30 p.m., Eastern Time, March 24, 2015. Public Comment Time and Date: 5:00 p.m.–6:00 p.m.*, Eastern Time, March 23, 2015. * Please note that the public comment period may end before the time indicated, following the last call for comments. Members of the public who wish to provide public comments should plan to attend the public comment session at the start time listed. Place: Hilton Tampa Airport Westshore, 2225 N. Lois Avenue, Tampa, Florida 33607; Phone: (800) 445–8667; Fax: (813) 872–0603. Audio Conference Call via FTS Conferencing. The USA toll-free, dial-in number is 1–866–659–0537 with a pass code of 9933701. Live Meeting CONNECTION: https://www.livemeeting.com/cc/cdc/ join?id=GHFDT9&role=attend&pw= ABRWH; Meeting ID: GHFDT9; Entry Code: ABRWH. Status: Open to the public, limited only by the space available. The meeting space accommodates approximately 100 people. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines which have been promulgated by the Department of Health and Human Services (HHS) as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program, and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, and will expire on August 3, 2017. Purpose: This Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters for Discussion: The agenda for the Advisory Board meeting includes: NIOSH Program Update; Department of Labor Program Update; Department of Energy Program Update; Report by the Dose Reconstruction Review Methods Work Group; Dose Reconstruction Report to the Secretary; SEC Petitions Update; Site Profile review for: Pinellas Plant (Clearwater, Florida); SEC petitions for: Lawrence Livermore National Laboratory (1974–1995; Livermore, California), Idaho National Laboratory (1949–1970; Scoville, Idaho), and Argonne National Laboratory West (1951–1979; Scoville, Idaho); and Board Work Sessions. The agenda is subject to change as priorities dictate. In the event an individual cannot attend, written comments may be E:\FR\FM\25FEN1.SGM 25FEN1 mstockstill on DSK4VPTVN1PROD with NOTICES Federal Register / Vol. 81, No. 37 / Thursday, February 25, 2016 / Notices submitted to the contact person below well in advance of the meeting. Any written comments received will be provided at the meeting in accordance with the redaction policy provided below. Policy on Redation of Board Meeting Transcripts (Public Comment): (1) If a person making a comment gives his or her personal information, no attempt will be made to redact the name; however, NIOSH will redact other personally indentifiable information, such as contact information, social security numbers, case numbers, etc., of the commenter. (2) If an individual in making a statement reveals personal information (e.g., medical or employment information) about themselves that information will not usually be redacted. The NIOSH Freedom of Information Act (FOIA) coordinator will, however, review such revelations in accordance with the Federal Advisory Committee Act and if deemed appropriate, will redact such information. (3) If a commenter reveals personal information concerning a living third party, that information will be reviewed by the NIOSH FOIA coordinator, and upon determination, if deemed appropriated, such information will be redacted, unless the disclosure is made by the third party’s authorized representative under the Energy Employees Occupational Illness Compensation Program Act (EEOICPA) program. (4) In general, information concerning a deceased third party may be disclosed; however, such information will be redacted if (a) the disclosure is made by an individual other than the survivor claimant, a parent, spouse, or child, or the authorized representative of the deceased third party; (b) if it is unclear whether the third party is living or deceased; or (c) the information is unrelated or irrelevant to the purpose of the disclosure. The Board will take reasonable steps to ensure that individuals making public comment are aware of the fact that their comments (including their name, if provided) will appear in a transcript of the meeting posted on a public Web site. Such reasonable steps include: (a) A statement read at the start of each public comment period stating that transcripts will be posted and names of speakers will not be redacted; (b) A printed copy of the statement mentioned in (a) above will be displayed on the table where individuals sign up to make public comments; (c) A statement such as VerDate Sep<11>2014 19:51 Feb 24, 2016 Jkt 238001 outlined in (a) above will also appear with the agenda for a Board Meeting when it is posted on the NIOSH Web site; (d) A statement such as in (a) above will appear in the Federal Register Notice that announces Board and Subcommittee meetings. Contact Person for More Information: Theodore Katz, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., MS E–20, Atlanta, Georgia 30333, telephone: (513) 533–6800, toll free: 1– 800–CDC–INFO, email: dcas@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2016–03928 Filed 2–24–16; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Request for Nominations of Candidates To Serve on the Board of Scientific Counselors, Office of Public Health Preparedness and Response (BSC, OPHPR) The Centers for Disease Control and Prevention (CDC) is soliciting nominations for possible membership on the BSC, OPHPR. The BSC, OPHPR consists of 11 experts in the fields associated with public health preparedness and response. This board provides advice and guidance to the Secretary, Department of Health and Human Services (HHS), the Director, CDC, and the Director, OPHPR, concerning strategies and goals for the programs within the divisions; conducts peer-review of scientific programs; and monitors the overall strategic direction and focus of the divisions. The BSC, OPHPR may perform second-level peer review of applications for grants-in-aid for research and research training activities, cooperative agreements, and research contract proposals relating to the broad areas within the office (http:// www.cdc.gov/phpr/science/ counselors.htm). Nominations are being sought for individuals who have the expertise and PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 9479 qualifications necessary to contribute to accomplishment of the board’s objectives. Nominees will be selected based on expertise in the fields relevant to the issues addressed by the divisions within the coordinating office, including: business, crisis leadership, emergency response and management, engineering, epidemiology, health policy and management, informatics, laboratory science, medicine, mental and behavioral health, public health law, public health practice, risk communication, and social science. Federal employees will not be considered for membership. Members may be invited to serve for terms of up to four years. The U.S. Department of Health and Human Services policy stipulates that committee membership be balanced in terms of professional training and background, points of view represented, and the board’s function. Consideration is given to a broad representation of geographic areas within the U.S., with equitable representation of gender, all ethnic and racial groups, and persons with disabilities. Nominees must be U.S. citizens. The next cycle of selection of candidates will begin in the spring of 2016, for selection of potential nominees to replace members whose terms will end on September 30, 2016. Selection of members is based on candidates’ qualifications to contribute to the accomplishment of OPHPR objectives (http://www.cdc.gov/phpr/ about.htm). Candidates should submit the following items: D Current curriculum vitae, including complete contact information (telephone numbers, mailing address, email address) D At least one letter of recommendation from person(s) not employed by the U.S. Department of Health and Human Services. The deadline for receipt of all application materials (for consideration for term beginning October 1, 2016) is April 15, 2016. All files must be submitted electronically as email attachments to: CDR Christye Brown, c/o BSC OPHPR Coordinator, email: cbrown12@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and E:\FR\FM\25FEN1.SGM 25FEN1

Agencies

[Federal Register Volume 81, Number 37 (Thursday, February 25, 2016)]
[Notices]
[Pages 9478-9479]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-03928]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Board on Radiation and Worker Health (ABRWH or Advisory 
Board), National Institute for Occupational Safety and Health (NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42 
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC), 
announces the following meeting of the aforementioned committee:
    Times and Dates: 9:00 a.m.-5:00 p.m., Eastern Time, March 23, 2015; 
8:15 a.m.-12:30 p.m., Eastern Time, March 24, 2015.
    Public Comment Time and Date: 5:00 p.m.-6:00 p.m.*, Eastern Time, 
March 23, 2015.

    * Please note that the public comment period may end before the 
time indicated, following the last call for comments. Members of the 
public who wish to provide public comments should plan to attend the 
public comment session at the start time listed.

    Place: Hilton Tampa Airport Westshore, 2225 N. Lois Avenue, Tampa, 
Florida 33607; Phone: (800) 445-8667; Fax: (813) 872-0603. Audio 
Conference Call via FTS Conferencing. The USA toll-free, dial-in number 
is 1-866-659-0537 with a pass code of 9933701. Live Meeting CONNECTION: 
https://www.livemeeting.com/cc/cdc/join?id=GHFDT9&role=attend&pw=ABRWH; 
Meeting ID: GHFDT9; Entry Code: ABRWH.
    Status: Open to the public, limited only by the space available. 
The meeting space accommodates approximately 100 people.
    Background: The Advisory Board was established under the Energy 
Employees Occupational Illness Compensation Program Act of 2000 to 
advise the President on a variety of policy and technical functions 
required to implement and effectively manage the new compensation 
program. Key functions of the Advisory Board include providing advice 
on the development of probability of causation guidelines which have 
been promulgated by the Department of Health and Human Services (HHS) 
as a final rule, advice on methods of dose reconstruction which have 
also been promulgated by HHS as a final rule, advice on the scientific 
validity and quality of dose estimation and reconstruction efforts 
being performed for purposes of the compensation program, and advice on 
petitions to add classes of workers to the Special Exposure Cohort 
(SEC).
    In December 2000, the President delegated responsibility for 
funding, staffing, and operating the Advisory Board to HHS, which 
subsequently delegated this authority to the CDC. NIOSH implements this 
responsibility for CDC. The charter was issued on August 3, 2001, 
renewed at appropriate intervals, and will expire on August 3, 2017.
    Purpose: This Advisory Board is charged with (a) providing advice 
to the Secretary, HHS, on the development of guidelines under Executive 
Order 13179; (b) providing advice to the Secretary, HHS, on the 
scientific validity and quality of dose reconstruction efforts 
performed for this program; and (c) upon request by the Secretary, HHS, 
advising the Secretary on whether there is a class of employees at any 
Department of Energy facility who were exposed to radiation but for 
whom it is not feasible to estimate their radiation dose, and on 
whether there is reasonable likelihood that such radiation doses may 
have endangered the health of members of this class.
    Matters for Discussion: The agenda for the Advisory Board meeting 
includes: NIOSH Program Update; Department of Labor Program Update; 
Department of Energy Program Update; Report by the Dose Reconstruction 
Review Methods Work Group; Dose Reconstruction Report to the Secretary; 
SEC Petitions Update; Site Profile review for: Pinellas Plant 
(Clearwater, Florida); SEC petitions for: Lawrence Livermore National 
Laboratory (1974-1995; Livermore, California), Idaho National 
Laboratory (1949-1970; Scoville, Idaho), and Argonne National 
Laboratory West (1951-1979; Scoville, Idaho); and Board Work Sessions.
    The agenda is subject to change as priorities dictate.
    In the event an individual cannot attend, written comments may be

[[Page 9479]]

submitted to the contact person below well in advance of the meeting. 
Any written comments received will be provided at the meeting in 
accordance with the redaction policy provided below.
    Policy on Redation of Board Meeting Transcripts (Public Comment):
    (1) If a person making a comment gives his or her personal 
information, no attempt will be made to redact the name; however, NIOSH 
will redact other personally indentifiable information, such as contact 
information, social security numbers, case numbers, etc., of the 
commenter.
    (2) If an individual in making a statement reveals personal 
information (e.g., medical or employment information) about themselves 
that information will not usually be redacted. The NIOSH Freedom of 
Information Act (FOIA) coordinator will, however, review such 
revelations in accordance with the Federal Advisory Committee Act and 
if deemed appropriate, will redact such information.
    (3) If a commenter reveals personal information concerning a living 
third party, that information will be reviewed by the NIOSH FOIA 
coordinator, and upon determination, if deemed appropriated, such 
information will be redacted, unless the disclosure is made by the 
third party's authorized representative under the Energy Employees 
Occupational Illness Compensation Program Act (EEOICPA) program.
    (4) In general, information concerning a deceased third party may 
be disclosed; however, such information will be redacted if (a) the 
disclosure is made by an individual other than the survivor claimant, a 
parent, spouse, or child, or the authorized representative of the 
deceased third party; (b) if it is unclear whether the third party is 
living or deceased; or (c) the information is unrelated or irrelevant 
to the purpose of the disclosure.
    The Board will take reasonable steps to ensure that individuals 
making public comment are aware of the fact that their comments 
(including their name, if provided) will appear in a transcript of the 
meeting posted on a public Web site. Such reasonable steps include: (a) 
A statement read at the start of each public comment period stating 
that transcripts will be posted and names of speakers will not be 
redacted; (b) A printed copy of the statement mentioned in (a) above 
will be displayed on the table where individuals sign up to make public 
comments; (c) A statement such as outlined in (a) above will also 
appear with the agenda for a Board Meeting when it is posted on the 
NIOSH Web site; (d) A statement such as in (a) above will appear in the 
Federal Register Notice that announces Board and Subcommittee meetings.
    Contact Person for More Information: Theodore Katz, Designated 
Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., MS E-20, Atlanta, 
Georgia 30333, telephone: (513) 533-6800, toll free: 1-800-CDC-INFO, 
email: dcas@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2016-03928 Filed 2-24-16; 8:45 am]
 BILLING CODE 4163-18-P